全文获取类型
收费全文 | 962篇 |
免费 | 90篇 |
专业分类
儿科学 | 27篇 |
妇产科学 | 37篇 |
基础医学 | 122篇 |
口腔科学 | 10篇 |
临床医学 | 250篇 |
内科学 | 173篇 |
皮肤病学 | 8篇 |
神经病学 | 54篇 |
特种医学 | 39篇 |
外科学 | 71篇 |
综合类 | 18篇 |
一般理论 | 1篇 |
预防医学 | 127篇 |
眼科学 | 19篇 |
药学 | 39篇 |
肿瘤学 | 57篇 |
出版年
2022年 | 8篇 |
2021年 | 9篇 |
2020年 | 6篇 |
2019年 | 16篇 |
2018年 | 19篇 |
2017年 | 8篇 |
2016年 | 6篇 |
2015年 | 10篇 |
2014年 | 17篇 |
2013年 | 36篇 |
2012年 | 69篇 |
2011年 | 70篇 |
2010年 | 18篇 |
2009年 | 32篇 |
2008年 | 47篇 |
2007年 | 53篇 |
2006年 | 51篇 |
2005年 | 48篇 |
2004年 | 48篇 |
2003年 | 55篇 |
2002年 | 37篇 |
2001年 | 38篇 |
2000年 | 29篇 |
1999年 | 37篇 |
1998年 | 6篇 |
1997年 | 8篇 |
1996年 | 4篇 |
1995年 | 16篇 |
1994年 | 16篇 |
1993年 | 11篇 |
1992年 | 19篇 |
1991年 | 25篇 |
1990年 | 11篇 |
1989年 | 17篇 |
1988年 | 9篇 |
1987年 | 13篇 |
1986年 | 11篇 |
1985年 | 8篇 |
1984年 | 7篇 |
1983年 | 9篇 |
1981年 | 7篇 |
1980年 | 6篇 |
1979年 | 5篇 |
1978年 | 8篇 |
1977年 | 6篇 |
1976年 | 6篇 |
1974年 | 6篇 |
1973年 | 4篇 |
1969年 | 4篇 |
1965年 | 3篇 |
排序方式: 共有1052条查询结果,搜索用时 15 毫秒
11.
12.
Children with malignancy are immunosup-pressed and susceptible to serious infections with herpesviruses. The majority of children on chemotherapy for malignancy are seropositive for human herpesvirus-6 (HHV-6), and although HHV-6 has been demonstrated to be a pathogen in severely immunocompromised patients, whether this is the case for paediatric oncology patients is unknown. HHV-6 is secreted in saliva and in this study samples were examined prospectively for HHV-6 DNA in healthy children and those with malignancy. In a nested polymerase chain reaction (PCR), a 287 bp outer fragment and 163 inner fragment of HHV-6 DNA were amplified. The resulting amplimer contained a Hind III restriction site present only in “B” type HHV-6 and this was used to identify the type of HHV-6 amplified. In saliva from healthy control children, 74% (28/38) of samples were HHV-6 DNA-positive in either the supernate, pellet or both. In the patients, 58% (45/77) of all samples were HHV-6 DNA-positive. When sequential samples from twelve patients were examined the children appeared to fall into two groups: those who were frequently HHV-6 DNA-positive (60% of samples or more) and those who were rarely HHV-6 DNA-positive (33% of samples or less) (P < 0.0001). The only apparent difference between these two groups was that the less frequently HHV-6-positive group was more often febrile and unwell with neutro-paenia. Hind III digestion demonstrated all the positive samples to be “6” type HHV-6. Possible explanations for this difference in HHV-6 secretion between the patient groups are discussed. © Wiley-Liss, Inc. 相似文献
13.
14.
Fleming R Rehka P Deshpande N Jamieson ME Yates RW Lyall H 《Human reproduction (Oxford, England)》2000,15(7):1440-1445
There has been much debate about the role of luteinizing hormone (LH) during follicle stimulating hormone (FSH)-treated ovarian stimulation for assisted reproduction, where the endogenous LH is suppressed using a gonadotrophin-releasing hormone analogue. The requirement for LH in oestradiol biosynthesis is established, but other effects of 'insufficiency' are less clear, and little attention has been paid to the specific origin of the FSH used. The aim of this study was to examine the roles of profoundly suppressed circulating LH concentrations in cycles of ovarian stimulation for IVF, which were affected in two large separate cohorts of patients undergoing assisted reproduction. They were stimulated by either purified urinary FSH (MHP) or recombinant human FSH (rFSH). Within each dataset, outcomes were examined with respect to the circulating concentrations of LH in the mid-follicular phase, as plasma samples were stored prospectively, and assayed retrospectively. Patients with profoundly suppressed LH showed much reduced oestradiol concentrations at mid-follicular phase and at human chorionic gonadotrophin administration in cycles treated with either MHP or rFSH. However, gross ovarian response, as became evident by FSH dose demands, duration of stimulation, and also oocyte and embryo yields and embryo cryopreservation were influenced only in cycles treated with MHP. Furthermore, no effect upon pregnancy survival was observed. Thus, it is concluded that there is a demand for additional exogenous LH treatment only in cycles treated with purified urinary FSH where the LH is profoundly suppressed. 相似文献
15.
16.
Lyall J Creswell J Millar B Turner T Ogden J Eaton L 《The Health service journal》1994,104(5391):suppl 1-2, 5-6, 9-16
17.
18.
19.
Lyall J 《The Health service journal》1995,105(5440):suppl 1-suppl 2
20.
OBJECTIVE: To assess the antibody response to influenza vaccine of children vertically infected with HIV. DESIGN: Prospective study in HIV infected children vaccinated during the winter of 1994-5. SETTING: Family HIV clinic at St Mary's Hospital, Paddington. SUBJECTS: 25 children, aged 1-11 years, vertically infected with HIV. MAIN OUTCOME MEASURES: Responses to influenza antigens (H1N1-A/Taiwan/1/86, H3N2-A/Shandong/9/93, B/Panama/45/ 90) were tested by haemagglutination inhibition. Antibody responses were assessed according to clinical symptoms and immune function, stratified according to the 1994 revised classification for HIV infection in children. RESULTS: 23 children (92%) had either very low or no detectable antibody before vaccination. New protective antibody responses were made by 10 children (40%): in seven to a single antigen, in two to two antigens, and in one to all three antigens. For each antigen there was an overall small increase in the mean geometric titre of antibody produced, but this only reached a protective level for antigen H1N1 and for children with minimal symptoms. Less symptomatic children were significantly more likely to produce a protective antibody response to influenza vaccination. No association was found between immune function, as measured by CD4 count, and vaccine response. CONCLUSIONS: Only vaccination of the least symptomatic HIV infected children against influenza is likely to be effective. This will not only protect them against influenza, but will also protect other more immunosuppressed and vulnerable members of their families. 相似文献